Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
- 1 June 1983
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 80 (11) , 3178-3182
- https://doi.org/10.1073/pnas.80.11.3178
Abstract
Thiorphan, N-[(R,S)-3-mercapto-2-benzylpropanoyl]glycine is a highly potent inhibitor (Ki [inhibition constant] = 3.5 nM) of enkephalinase, a metalloendopeptidase cleaving the Gly-Phe bond (positions 3 and 4) of enkephalins in brain tissue. In accordance with this property, thiorphan displays antinociceptive activity after systemic administration. Thiorphan also inhibits to a lesser extent (Ki = 140 nM) the widely distributed angiotensin-converting enzyme, a carboxydipeptidase implicated in blood pressure regulation. In view of an eventual clinical use of enkephalinase inhibitors, fully specific compounds were developed. Such derivatives were obtained taking into account that N-methylation of the ultimate amide bond of dipeptides strongly decreases enkephalinase affinity without affecting angiotensin-converting enzyme recognition, whereas retro-inversion of the amide bond leads to the inverse effect. The retro-inverso dipeptide (R)-H2N-CH(CH2.vphi.)-NHCO-CH2-CO2H exhibits an inhibitory potency on enkephalinase (IC50 .simeq. 12 .mu.M) close to that of the natural dipeptide L-Phe-Gly (IC50 .simeq. 3 .mu.M). This result shows the topological analogy between the crucial components involved in enkephalinase recognition both in active dipeptides and structurally related retro-inverso isomers. Taking into account these observations, retro-thiorphan, (R,S)-HS-CH2-CH-(CH2.vphi.)-NHCO-CH2-COOH, was prepared. As compared to thiorphan, the retro isomer is 50% as potent (Ki = 6 nM) on enkephalinase but displays a drastic loss of potency on angiotensin-converting enzyme (IC50 > 10,000 nM). This specificity was interpreted as a consequence of differences in the stereochemical constraints involving enzyme-inhibitor H-bonding. This hypothesis is supported by reported crystallographic studies on related enzymes such as thermolysin and carboxypeptidase A. As expected, retro-thiorphan exhibits about the same analgesic potency as thiorphan on the hot plate and writhing tests in mice. The topological concept of retro-inverso isomers could be extended to other enkephalinase inhibitors, allowing the design of potent and highly selective compounds occurring as new classes of analgesic and psychoactive agents.This publication has 33 references indexed in Scilit:
- New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity and analgesic propertiesJournal of Medicinal Chemistry, 1983
- Thiorphan potentiation of stress-induced analgesia in the mouseLife Sciences, 1982
- Multiple molecular forms of rat brain enkephalinaseLife Sciences, 1982
- Structure of a mercaptan-thermolysin complex illustrates mode of inhibition of zinc proteases by substrate-analog mercaptansBiochemistry, 1982
- Properties of “enkephalinase” from rat kidney: Comparison of dipeptidyl-carboxypeptidase and endopeptidase activitiesBiochemical and Biophysical Research Communications, 1982
- Rational design of enkephalinase inhibitors: Substrate specificity of enkephalinase studied from inhibitory potency of various dipeptidesBiochemical and Biophysical Research Communications, 1980
- Two distinct enkephalinases: Solubilization, partial purification and separation from angiotensin converting enzymeLife Sciences, 1979
- Inhibitory potency of various peptides on enkephalinase activity from mouse striatumBiochemical and Biophysical Research Communications, 1979
- Co-identity of brain angiotensin converting enzyme with a membrane bound dipeptidyl carboxypeptidase inactivating Met-enkephalinBiochemical and Biophysical Research Communications, 1979
- A crystallographic study of the complex of phosphoramidon with thermolysin. A model for the presumed catalytic transition state and for the binding of extended substratesJournal of Molecular Biology, 1977